An antibody targeting the truncated Annexin A1 protein was shown to rapidly pump across the tumor endothelium, reaching >100 fold more than other antibodies and exceeding peak blood fluorescence signal within one hour. This evidence concerns the gene ANXA1 and neoplasm.